Participants announced for National Healthcare Congress 2024 business programme

The 3^rd National Congress with International Participation “National Healthcare” has released the expanded business programme for the event on its website with a full list of participants in expert discussions. The Congress is being held with the support of the Russian government and organized by the Russian Ministry of Health and the Roscongress Foundation. The organizing partner of the event is the Russian Research Institute of Health of the Russian Ministry of Health.

“The National Healthcare Congress has become a landmark event that underscores the importance of healthcare as one of the state’s priorities, since the health of citizens is the foundation of society’s prosperity and sustainable development. For the third year, the Congress provided a platform to exchange experience and best practices, which makes a tangible contribution to healthcare and defines new trajectories for the development of the industry,” Adviser to the President of the Russian Federation Anton Kobyakov said.

The Congress will take place at the Lomonosov Cluster of the Sparrow Hills ISTC of Moscow State University on 28 October 2024 and the Great Hall of the State Kremlin Palace on 29 October 2024.

“To achieve the national goals as part of the policy to preserve the population, it is crucial for healthcare leaders, government officials, the scientific community, business, and experts working on healthy lifestyle issues to consolidate their efforts. The heads of regional ministries and healthcare agencies are taking part in the work of the National Healthcare Congress, where the best practices of the regions and practices that are ready to be scaled up to the federal level will be presented. The Congress has practical significance for developing healthcare and improving the quality and life expectancy of citizens,” Minister of Health of the Russian Federation Mikhail Murashko said.

The event will be attended by Russian Deputy Prime Minister Tatyana Golikova; Russian Minister of Health Mikhail Murashko; Russian Federation Council Deputy Chairperson Inna Svyatenko; Deputy Chief of Staff of the Russian Government Olga Krivonos; Russian Minister of Science and Higher Education Valery Falkov; Director of the Russian Federal Service for the Oversight of Consumer Protection and Welfare and Chief State Sanitary Doctor of the Russian Federation Anna Popova; Director of the Healthcare Department of the Russian Government Igor Kagramanyan; First Deputy Director of the Russian Federal Medical-Biological Agency Tatyana Yakovleva; Russian Deputy Minister of Industry and Trade Yekaterina Priyezzheva; Director of the Russian Federal Service for Surveillance in Healthcare Alla Samoylova; Chairman of the Russian Federal Compulsory Medical Insurance Fund Ilya Balanin; Vice President of the Russian Academy of Sciences Mikhail Piradov; Chairman of the Russian Society of Historians of Medicine Konstantin Pashkov; Director of the Central Healthcare Directorate – Branch of Russian Railways Yelena Zhidkova; Director of the National Medical Research Centre for Therapy and Preventive Medicine and Chief Specialist in Therapy and General Medical Practice of the Russian Ministry of Health Oksana Drapkina; Director General of the National Medical Research Radiological Centre and Chief Oncologist of the Russian Ministry of Health Andrey Kaprin; General Director of the Almazov National Medical Research Centre and Chief Cardiologist of the Russian Ministry of Health Yevgeny Shlyakhto; President of the Union of Paediatricians of Russia and Chief Paediatrician in Preventive Medicine of the Russian Ministry of Health Leyla Namazova-Baranova; Director of the Russian Research Institute of Health of the Russian Ministry of Health Olga Kobyakova; Skopinpharm CEO Inga Nizharadze; Nizhpharm Group CEO Oksana Pozdnyakova; Deputy General Director for Ensuring Access of Drugs to the Market and Oncology of Swix Healthcare Alisa Dzhangiryants; Managing Director for Budget Sales of NPO Petrovax Pharm Vladislava Torshina; R-Pharm CEO Vasily Ignatyev; Adviser to the CEO of Kapital Medical Insurance Alexey Starchenko; Managing Director for Biotechnology Portfolio Development of NPO Petrovax Pharm Andrey Boldyrev; Medical Director of Sun Pharma’s Ranbaxy Viktoria Vargina; Beauty Bite Founder Inna Bogdanova; Executive Director of the Association of International Pharmaceutical Manufacturers Larisa Matveyeva, as well as regional ministers of health and foreign partners.

The National Healthcare Congress is a flagship gala event for the medical community and the healthcare sector as a whole, which brings together industry leaders and managers, representatives of the legislative and executive authorities at the federal and regional levels, as well as leading Russian and foreign experts and opinion leaders to discuss the most pressing issues in healthcare, the modernization of the industry, and ways to strengthen public health in order to increase people’s life expectancy and improve their quality of life.